In this study, we identified the target of four kusunokinin enantiomers (trans-(−), trans-(+), cis-(−) and cis-(+)-isomer) on 60 candidate proteins related to the CSF1R-breast cancer progression pathway and proposed a preferable form of kusunokinin isomers using molecular docking and our scoring system. This evidence concerns the gene CSF1R and breast carcinoma.